Company intelligence / Profile preview

Immunexpress

Seattle, Washington, USAimmunexpress.com ↗

Ownership: Private
Development stage: Commercial

Overview

Immunexpress has developed and commercialized the SeptiCyte® RAPID test, which uses host gene expression analysis to rapidly rule-in or rule-out sepsis. The test delivers actionable results within one hour and has been validated through extensive global clinical trials. It provides a significant improvement over traditional pathogen-based diagnostics, which can take up to two days for results. Clinical data supports its accuracy and utility in improving patient outcomes by enabling faster treatment decisions.

Therapeutic areas: Infectious Diseases
Modalities: Device (diagnostic device)Molecular diagnostic testGene expression assay
Industry: Molecular Diagnostics

Drug pipeline

1 asset

SeptiCyte RAPID

Commercial

Indications: Sepsis

Partnerships

Biocartis (Idylla™ platform partnership for cartridge compatibility)

Beyond the preview

Go deeper on Immunexpress.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunexpress.

Explore the full profile